Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Individualized Chemotherapy (Zhejiang University)
- Development stage
- Unknown
- Lead developer
- Zhejiang University
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Individualized Chemotherapy (Zhejiang University) refers to a personalized adjuvant treatment protocol for patients with hepatocellular carcinoma (HCC) following liver transplantation. This strategy utilizes the Adenosine Triphosphate Tumor Chemosensitivity Assay (ATP-TCA) to select the most effective two-drug chemotherapy combination for each patient from a predefined panel of cytotoxic agents. The candidate drugs include oxaliplatin, gemcitabine, irinotecan, paclitaxel, docetaxel, fluorouracil, doxorubicin, and cisplatin. By tailoring the chemotherapy regimen to the specific ex vivo sensitivity of the patient's tumor cells, the protocol aims to minimize recurrence and improve overall survival compared to standardized regimens like mFOLFOX6.
- Other names
- Individualized Adjuvant ChemotherapyATP-TCA guided chemotherapyindividualized chemotherapy-Zhejiang University-hepatocellular carcinoma
02
Targets
DNA
Beyond the preview
Go deeper on Individualized Chemotherapy (Zhejiang University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Individualized Chemotherapy (Zhejiang University).